A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function
NCT02005744
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Liver Dysfunction
Interventions
DRUG:
CKD-501
Sponsor
Chong Kun Dang Pharmaceutical